Intravenous Immunoglobulin in Treating Nonventilated COVID-19 Patients with Moderate-to-Severe Hypoxia: A Pharmacoeconomic Analysis

Category Primary study
JournalJournal of Clinical Outcomes Management
Year 2022
This article has no abstract
Epistemonikos ID: d17af499e534f3006fab0a84cc4e035c8f64f77d
First added on: Feb 15, 2025